36 related articles for article (PubMed ID: 15274364)
21. Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma.
Sznol M; Dutcher JP; Atkins MB; Rayner AR; Margolin KA; Gaynor ER; Weiss GR; Aronson F; Parkinson DR; Hawkins MJ
Cancer Treat Rev; 1989 Jun; 16 Suppl A():29-38. PubMed ID: 2670213
[No Abstract] [Full Text] [Related]
22. Histamine: a novel approach to cancer immunotherapy.
Hellstrand K; Brune M; Naredi P; Mellqvist UH; Hansson M; Gehlsen KR; Hermodsson S
Cancer Invest; 2000; 18(4):347-55. PubMed ID: 10808371
[TBL] [Abstract][Full Text] [Related]
23. Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment.
Agarwala SS; Sabbagh MH
Expert Opin Biol Ther; 2001 Sep; 1(5):869-79. PubMed ID: 11728221
[TBL] [Abstract][Full Text] [Related]
24. Systemic therapy of melanoma.
Kirkwood JM
Curr Opin Oncol; 1994 Mar; 6(2):204-11. PubMed ID: 8011698
[TBL] [Abstract][Full Text] [Related]
25. Recombinant interleukin-2 and recombinant interferon alpha immunotherapy cardiovascular toxicity.
Schechter D; Nagler A
Am Heart J; 1992 Jun; 123(6):1736-9. PubMed ID: 1595573
[No Abstract] [Full Text] [Related]
26. Combined treatment with histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma.
Lindnér P; Rizell M; Mattsson J; Hellstrand K; Naredi P
Anticancer Res; 2004; 24(3b):1837-42. PubMed ID: 15274364
[TBL] [Abstract][Full Text] [Related]
27. New approaches to the systemic treatment of melanoma.
Chowdhury S; Vaughan MM; Gore ME
Cancer Treat Rev; 1999 Oct; 25(5):259-70. PubMed ID: 10544070
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of metastasized malignant melanoma].
Kamanabrou D
Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
[TBL] [Abstract][Full Text] [Related]
29. Histamine and cytokine therapy.
Hellstrand K; Hermodsson S; Naredi P; Mellqvist UH; Brune M
Acta Oncol; 1998; 37(4):347-53. PubMed ID: 9743456
[TBL] [Abstract][Full Text] [Related]
30. Histamine dihydrochloride: in the management of acute myeloid leukaemia.
Yang LP; Perry CM
Drugs; 2011 Jan; 71(1):109-22. PubMed ID: 21175244
[TBL] [Abstract][Full Text] [Related]
31. Histamine in cancer immunotherapy.
Hellstrand K; Hermodsson S; Brune M; Naredi P; Carneskog J; Mellqvist UH
Scand J Clin Lab Invest; 1997 May; 57(3):193-202. PubMed ID: 9238754
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]